What are the best outcome measurements for atopic eczema? A systematic review
Top Cited Papers
- 2 October 2007
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 120 (6), 1389-1398
- https://doi.org/10.1016/j.jaci.2007.08.011
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Cyclosporin in the treatment of patients with atopic eczema – a systematic review and meta‐analysisJournal of the European Academy of Dermatology and Venereology, 2007
- Tacrolimus Ointment 0.03% Is Safe and Effective for the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Patients: Results From a Randomized, Double-Blind, Vehicle-Controlled StudyPediatrics, 2005
- Atopic DermatitisNew England Journal of Medicine, 2005
- The Patient-Oriented Eczema MeasureArchives of Dermatology, 2004
- Influence of Pimecrolimus Cream 1% on Different Morphological Signs of Eczema in Infants with Atopic DermatitisDermatology, 2004
- Quality of life and disease severity are correlated in children with atopic dermatitisBritish Journal of Dermatology, 2004
- Disease severity and associated family impact in childhood atopic dermatitisArchives of Disease in Childhood, 2003
- Atopic dermatitisThe Lancet, 2003
- Clinical Validation and Guidelines for the SCORAD Index: Consensus Report of the European Task Force on Atopic DermatitisDermatology, 1997
- Six Area, Six Sign Atopic Dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis*British Journal of Dermatology, 1996